BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15501030)

  • 1. In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones.
    Maccari R; Ottanà R; Bottari B; Rotondo E; Vigorita MG
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5731-3. PubMed ID: 15501030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro advanced antimycobacterial screening of isoniazid-related hydrazones, hydrazides and cyanoboranes: part 14.
    Maccari R; Ottanà R; Vigorita MG
    Bioorg Med Chem Lett; 2005 May; 15(10):2509-13. PubMed ID: 15863306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New series of isoniazid hydrazones linked with electron-withdrawing substituents.
    Vavříková E; Polanc S; Kočevar M; Košmrlj J; Horváti K; Bosze S; Stolaříková J; Imramovský A; Vinšová J
    Eur J Med Chem; 2011 Dec; 46(12):5902-9. PubMed ID: 22018878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro tuberculostatic activity of Co (II), Cu (II) and Ni (II) complexes of dialdehyde starch dithiosemicarbazone.
    Para A; Klisiewicz-Pańszczyk T; Jurek I
    Acta Pol Pharm; 2001; 58(5):405-8. PubMed ID: 11876449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
    Foroumadi A; Soltani F
    Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity.
    Barbachyn MR; Hutchinson DK; Brickner SJ; Cynamon MH; Kilburn JO; Klemens SP; Glickman SE; Grega KC; Hendges SK; Toops DS; Ford CW; Zurenko GE
    J Med Chem; 1996 Feb; 39(3):680-5. PubMed ID: 8576910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumor studies on novel Co(II), Ni(II) and Cu(II) metal complexes of bis(3-acetylcoumarin)thiocarbohydrazone.
    Sathisha MP; Shetti UN; Revankar VK; Pai KS
    Eur J Med Chem; 2008 Nov; 43(11):2338-46. PubMed ID: 18023933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9.
    Bottari B; Maccari R; Monforte F; Ottanà R; Rotondo E; Vigorita MG
    Bioorg Med Chem Lett; 2000 Apr; 10(7):657-60. PubMed ID: 10762047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co(II) and Cu(II) pyrophosphate complexes have selectivity and potency against Mycobacteria including Mycobacterium tuberculosis.
    Hoffman AE; DeStefano M; Shoen C; Gopinath K; Warner DF; Cynamon M; Doyle RP
    Eur J Med Chem; 2013; 70():589-93. PubMed ID: 24211634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, characterisation and antitubercular activities of a series of pyruvate-containing aroylhydrazones and their Cu-complexes.
    Jamadar A; Duhme-Klair AK; Vemuri K; Sritharan M; Dandawate P; Padhye S
    Dalton Trans; 2012 Aug; 41(30):9192-201. PubMed ID: 22717728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antimycobacterial activity of an antihypertensive agent methyl-L-DOPA.
    Dutta NK; Mazumdar K; Dastidar SG; Chakrabarty AN; Shirataki Y; Motohashi N
    In Vivo; 2005; 19(3):539-45. PubMed ID: 15875773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2005 Oct; 251(1):19-22. PubMed ID: 16143463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages.
    Sood R; Rao M; Singhal S; Rattan A
    Int J Antimicrob Agents; 2005 Jun; 25(6):464-8. PubMed ID: 15885988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
    Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of isonicotinoylhydrazones from anacardic acid and their in vitro activity against Mycobacterium smegmatis.
    Swamy BN; Suma TK; Rao GV; Reddy GC
    Eur J Med Chem; 2007 Mar; 42(3):420-4. PubMed ID: 17112641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexes of 2-thiophenecarbonyl and isonicotinoyl hydrazones of 3-(N-methyl)isatin. A study of their antimicrobial activity.
    Rodríguez-Argüelles MC; Mosquera-Vázquez S; Tourón-Touceda P; Sanmartín-Matalobos J; García-Deibe AM; Belicchi-Ferrari M; Pelosi G; Pelizzi C; Zani F
    J Inorg Biochem; 2007 Jan; 101(1):138-47. PubMed ID: 17070919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and in vitro antimycobacterial activity of 3-substituted 5-hydroxy-5-trifluoro[chloro]methyl-4,5-dihydro-1H-1-(isonicotinoyl) pyrazoles.
    Almeida da Silva PE; Ramos DF; Bonacorso HG; de la Iglesia AI; Oliveira MR; Coelho T; Navarini J; Morbidoni HR; Zanatta N; Martins MA
    Int J Antimicrob Agents; 2008 Aug; 32(2):139-44. PubMed ID: 18571384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro antimicrobial and antitumoral screening of novel lipophilic isoniazid analogues. VI.
    Vigorita MG; Ottanà R; Maccari R; Monforte F; Bisignano G; Pizzimenti FC
    Boll Chim Farm; 1998; 137(7):267-76. PubMed ID: 9795482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.